PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study identifies genetic mutations associated with tumor of adrenal gland

2010-12-15
(Press-News.org) Analysis has identified variations of a gene that are associated with a type of tumor that forms within the adrenal gland, according a study in the December 15 issue of JAMA. The age group in which these variations were found are frequently excluded from genetic screening models for this type of tumor.

Pheochromocytomas and paragangliomas are types of tumors. Pheochromocytomas form in the adrenal gland (gland located above the kidney) causing it to make too much adrenaline. Pheochromocytomas can cause high blood pressure, pounding headaches, heart palpitations, flushing of the face, nausea, and vomiting. Paragangliomas are rare, usually benign tumors that may develop at various body sites. Despite a broad spectrum of susceptibility genes for these tumors, the molecular basis for the majority of pheochromocytomas and paragangliomas, including most of the sporadic and rare familial cases, remains unknown, according to background information in the article. "These observations support the existence of additional pheochromocytoma susceptibility genes, which may account for some of the genetically undefined cases," the authors write.

Li Yao, Ph.D., of the University of Texas Health Science Center at San Antonio, and colleagues conducted a study to determine the prevalence in pheochromocytomas and paragangliomas of mutations in the gene FP/TMEM127, a recently identified pheochromocytoma susceptibility gene. The researchers sequenced the FP/TMEM127 gene in 990 individuals with pheochromocytomas and/or paragangliomas, including 898 previously unreported cases without mutations in other susceptibility genes from 8 independent worldwide referral centers between January 2009 and June 2010.

The researchers detected a total of 44 distinct FP/TMEM127 variants in 990 samples from pheochromocytoma or paraganglioma patients. "Of these, 19 mutations found in 20 patients were considered of potential pathogenic significance. Thirteen of these variants were novel changes, while the remainder had been previously reported," the authors write. Mutations were detected only in patients with tumors of adrenal localization (pheochromocytomas) but not with paragangliomas.

The average age at development of FP/TMEM127-mutated tumors was 42.8 years and the median (midpoint) age was 41.5 years, with this age at onset similar to the average age of non-mutated cases in this series, 43.2 years (median, 45 years) and to the reported average diagnostic age for sporadic pheochromocytomas (47 years). The most common presentation was that of a single benign adrenal tumor in patients older than 40 years. Malignancy was seen in 1 mutation carrier (5 percent).

"Germline mutations of FP/TMEM127 were associated with pheochromocytoma but not paraganglioma and occurred in an age group frequently excluded from genetic screening algorithms," the authors write. "Future studies should determine quantitative intracellular effects of individual variants."

###

(JAMA. 2010;304[23]:2611-2619. Available pre-embargo to the media at www.jamamedia.org)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

To contact corresponding author Patricia L.M. Dahia, M.D., Ph.D., call Elizabeth Allen at 210-450-2020 or email allenea@UTHSCSA.edu.

For More Information: Contact the JAMA/Archives Media Relations Department at 312-464-JAMA or email: mediarelations@jama-archives.org.

END



ELSE PRESS RELEASES FROM THIS DATE:

Zebrafish provide new hope for cancer treatment

2010-12-15
The imaging of tumour growth in zebrafish has revealed for the first time how newly formed cancer cells have the capacity to co-opt the immune system into spreading the disease, leading the way for investigations into potential therapies for eliminating early-stage cancer in humans. Using different coloured fluorescent tags, scientists at the University of Bristol labelled immune cells and tumour-forming cells in the translucent zebrafish in order to track their behaviour and interactions by live cell imaging. These dramatic findings, which are the result of a collaboration ...

Researchers discover compound with potent effects on the biological clock

2010-12-15
Using automated screening techniques developed by pharmaceutical companies to find new drugs, researchers from UC San Diego and three other research institutions have discovered a molecule with the most potent effects ever seen on the biological clock. Dubbed "longdaysin," for its ability to dramatically slow down the biological clock, the new compound could pave the way for a host of new drugs to treat severe sleep disorders or quickly reset the biological clocks of jet-lagged travelers who regularly travel across multiple time zones. The researchers demonstrated the dramatic ...

Neonatal intensive care in Mexico is cost effective

2010-12-15
Neonatal intensive care provides substantial population health benefits in Mexico relative to its costs, even for very premature babies, and as such offers exceptional value for money within the country's Popular Health Insurance (Seguro Popular) program, which offers free access to a specific set of health care interventions. Furthermore, neonatal intensive care could also be cost effective in other middle-income countries. These are the findings of a study by Jochen Profit from Baylor College of Medicine, Houston, USA, Joshua Salomon from the Harvard School of Public ...

Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae

2010-12-15
Jeremy Keenan and colleagues report that during a cluster-randomized clinical trial in Ethiopia, nasopharyngeal pneumococcal resistance to macrolides was significantly higher in communities randomized to receive azithromycin compared with untreated control communities. Funding: The National Institutes of Health (NEI U10 EY016214) was the main supporter of this trial. This project was also supported by the Bernard Osher Foundation, That Man May See, the Harper Inglis Trust, the Bodri Foundation, the South Asia Research Fund, Research to Prevent Blindness, NIH/NCRR/OD UCSF-CTSI ...

Enhanced brain-machine interface taps into additional senses

Enhanced brain-machine interface taps into additional senses
2010-12-15
Washington, DC — Monkeys moved thought-controlled computer cursors more quickly and accurately when provided with additional sensory feedback, according to a new study in the Dec. 15 issue of The Journal of Neuroscience. While most brain-machine technologies rely only on visual feedback, this study demonstrated that these systems can be improved when users have additional input, such as a sense of the arm's position and motion, a sensation known as proprioception. With the aid of brain-controlled devices, paralyzed people have been able to send e-mail, ...

Champion hydrogen-producing microbe

Champion hydrogen-producing microbe
2010-12-15
Inside a small cabinet the size of a dorm refrigerator in one of Himadri B. Pakrasi's labs, a blue-green soup percolates in thick glass bottles under the cool light of red, blue and green LEDS. This isn't just any soup, however. It is a soup of champions. The soup is colored by a strain of blue-green bacteria that bubble off roughly 10 times the hydrogen gas produced by their nearest competitors—in part because of their unique genetic endowment but also in part because of tricks the scientists have played on their metabolism. Hydrogen gas can be produced by microbes ...

Gene information predicts survival time, possible new treatment options for lung-cancer patients

2010-12-15
DALLAS – Dec. 14, 2010 – Researchers at UT Southwestern Medical Center have discovered sets of genes active in cancer cells and normal tissue that predict survival time and potential new treatments for patients with non-small cell lung cancer. "Patient responses to cancer treatment vary widely and often depend on subtle biological differences among tumors," said Dr. David Mangelsdorf, chairman of pharmacology at UT Southwestern and co-lead author of the study, published Dec. 14 by PLoS Medicine. "These findings are important because the ability to determine which genes ...

The key to being attractive (and looking healthy)? A good night's sleep

2010-12-15
If you want to look attractive and healthy, the best thing you can do is get a good night's sleep, finds research in the Christmas issue published on bmj.com today. For the first time, say the authors, there is scientific backing for the concept of beauty sleep. The study, led by John Axelsson from the Karolinska Institutet in Sweden, investigated the relationship between sleep and perceptions of attractiveness and health. The authors believe this research is important in today's 24 hour society with the number of people suffering from sleep disorders and disturbed ...

Drinking alcohol during a rich meal slows down digestion, but doesn't increase indigestion

2010-12-15
People can be reassured that while alcohol may slow down digestion after a rich calorific meal, enjoyed by many during the Christmas season, it will not cause indigestion symptoms such as heartburn, belching and bloating, finds research in the Christmas issue published on bmj.com today. In order to determine the effects of alcohol on the digestive system when rich meals are consumed, investigators at the University Hospital of Zurich, led by Dr Mark Fox now at the Queens Medical Centre in Nottingham, studied 20 individuals who either drank wine or black tea with cheese ...

Submerging your feet in alcohol will not get you drunk

2010-12-15
Research in the Christmas issue published on bmj.com today explodes the Danish myth that it is possible to get drunk by submerging your feet in alcohol. The authors, led by Dr Peter Lommer Kristensen from the Hillerød Hospital in Denmark, say it was important that the myth underwent scientific scrutiny to prevent students wasting their time experimenting with this activity. Three adult volunteers took part in the study. None of them suffered from any chronic skin or liver disease and they were not addicted to alcohol or psychoactive drugs. The participants were not ...

LAST 30 PRESS RELEASES:

Are you eligible for a clinical trial? ChatGPT can find out

New treatment could reduce brain damage from stroke, study in mice shows

4,000-year-old teeth record the earliest traces of people chewing psychoactive betel nuts

Efficient solar harvesting even in high humidity

Heavy drinking raises the risk of undesired pregnancy; cannabis use does not

New study shows young adults who use high strength cannabis do not ‘titrate’ to less risky levels of use

Black hole vibes

Actual distance travelled by migrating whales drastically underestimated

The eagles resistant to poisonous toads

Cyberstalking growing at faster rate than other forms of stalking

CPADS: a web tool for comprehensive pancancer analysis of drug sensitivity

Several healthy diet patterns are associated with reduced risk of type 2 diabetes regardless of ethnicity – shows meta-analysis of more than 800,000 people

Liver fibrosis to cancer: scientists map path to block deadly transition

Microbiota boost immunotherapy? A meta-analysis dives into fecal microbiota transplantation and immune checkpoint inhibitors

Cancer's double agents: Fibroblasts both help and hinder immunotherapy

Unveiling large multimodal models in pulmonary CT: A comparative assessment of generative AI performance in lung cancer diagnostics

AI can fake peer reviews and escape detection, study finds

T cell senescence in the tumor microenvironment

Simple solution to save lives globally: Low-cost ‘SimpleSilo’ offers hope for babies with gastroschisis

Curbing roadway fatalities hinges on shared responsibility and rethinking safety

Beta-HPV can directly cause skin cancer in immunocompromised people

Efforts underway to end race-based assessments of lung function

CAR-T cell therapy linked to increased risk of secondary primary malignancies globally

THER: integrative web tool for tumor hypoxia exploration and research

How sources of dietary fat influence cancer growth in obesity

Women less likely than men to receive MS drugs

AI language models sharpen chest CT diagnoses, speeding surgical decisions

Machine learning model predicts which patients with nasopharyngeal cancer respond to radiation

GenAI models extract pathological features for lung adenocarcinoma grading and prognosis

New research further investigates safety of general anesthesia in infants

[Press-News.org] Study identifies genetic mutations associated with tumor of adrenal gland